4.7 Article

Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway

Journal

PHYTOMEDICINE
Volume 103, Issue -, Pages -

Publisher

ELSEVIER GMBH
DOI: 10.1016/j.phymed.2022.154219

Keywords

Fatty acid metabolism; Saikosaponins D; Metabolic associated fatty liver disease; PPAR alpha; SREBP1c; INSIGs

Funding

  1. National Natural Science Foundation of China [82004029]
  2. Beijing Nova Program of Science Technology [Z201100006820025, Z211100002121167]

Ask authors/readers for more resources

This study investigated the mechanisms of Saikosaponin D (SSd) in metabolic associated fatty liver disease (MAFLD) and found that SSd improved lipid accumulation by regulating PPAR alpha activation to inhibit fatty acid synthesis and induce degradation. This provides a new perspective for therapeutic strategies in MAFLD.
Background: Metabolic associated fatty liver disease (MAFLD) is a progressive chronic liver disease, yet there is still a lack of effective pharmacological therapies at present. Saikosaponin D (SSd) has been reported to exhibit hepatoprotective and anti-steatosis activities in our previous research. Purpose: The current study aims to further investigate the underlying mechanisms of SSd on MAFLD from the perspectives of the crosstalk between fatty acid (FA) biosynthesis and catabolism to provide strong support for further clinical management of MAFLD. Methods: A MAFLD mouse model induced by a high-fat diet and glucose-fructose water (HFSW) was used for in vivo study. HepG2 cells, primary mouse hepatocytes and adipocytes were further employed for in vitro studies. Results: SSd improved intracellular lipid accumulation both in the liver and adipose tissues in HFSW-fed mice. Mechanistically, SSd may serve as a potent PPAR alpha agonist, and the activation of PPAR alpha by SSd in both hepatocytes and adipocytes not only promoted FA oxidation but also concurrently induced INSIG1/2 expression, which subsequently inhibited SREBP1c maturation and ultimately FA synthesis. Moreover, the regulative effect of SSd on lipid metabolism was abolished by the PPAR alpha inhibitor, GW6471. Conclusion: This study demonstrated that SSd improved lipid homeostasis by coordinately regulating PPAR alpha activation-mediated both inhibition of SREBP1c-dependent FA biosynthesis and induction of FA degradation, and thus shed novel light on the discovery of SSd-based therapeutic strategies for MAFLD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available